Xuanzhu Biopharmaceutical Co., Ltd. (HKG:2575)
24.00
-0.60 (-2.44%)
Apr 29, 2026, 4:08 PM HKT
Xuanzhu Biopharmaceutical Market Cap
Xuanzhu Biopharmaceutical has a market cap or net worth of 12.43 billion as of April 29, 2026.
Market Cap
12.43B
Enterprise Value
11.71B
Revenue
57.61M
Ranking
n/a
PE Ratio
n/a
Stock Price
24.00
Market Cap Chart
Since October 15, 2025, Xuanzhu Biopharmaceutical's market cap has decreased from 13.62B to 12.43B, a decrease of -8.75%. That is a compound annual growth rate of -15.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 12.74B | -65.11% |
| Dec 31, 2025 | 36.52B | 168.06% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CanSino Biologics | 12.90B |
| Sihuan Pharmaceutical Holdings Group | 11.94B |
| Consun Pharmaceutical Group | 13.56B |
| Ab&B Bio-Tech CO., LTD. JS | 11.54B |
| Luye Pharma Group | 10.67B |
| Shandong Xinhua Pharmaceutical Company | 9.43B |
| The United Laboratories International Holdings | 18.82B |
| China Traditional Chinese Medicine Holdings Co. | 8.41B |